A chemical investigation on the cultures of Xylaria carpophila led to the isolation of one known cyclopeptide (1), five new sesquiterpenes, named as xylcarpins AE (26), and another known compound (7). The structures were determined by extensive NMR and MS spectroscopic analysis. The absolute configuration of 1 was established by use of Marfey's method and ROESY spectroscopic data. All compounds were tested for their cytotoxicities against five human cancer cell lines. Compound 7 showed week inhibitory activity.
Introduction
Fungi of the genus Xylaria are known to produce many types of bioactive compounds. Previous studies revealed that isopimarane diterpene glycosides, 1 xylopimarane, 2 4,6,8 (14) ,22-tetraen-3-one, 3 xylarisin, 4 coloratin A, 5 kolokoside A, 6 cytochalasins, 7 clonostachydiol, 7 xylobovide, 7 07H239-A, 8 cytochalasin D, 9 multiplolides A and B, 10 sordaricin, 11 mellisol, 12 1,8-dihydroxynaphthol 1-O-α-glucopyranoside, 12 benzoquinones, 13 and integric acid 14 from some species of this genus showed diverse pharmacological properties, including cytotoxic, antimicrobial, antifungal, anthelmintic, antivirus, and antimalarial activities. But the chemical constituents of Xylaria carpophila have received little attention. Our current investigation on the cultures of X. carpophila led to the isolation of one known cyclopeptide, cyclo(N-methyl-L -Phe-L -Pro-L -Leu-D -Ile-L -Val) (1), five new sesquiterpenes, named as xylcarpins A-E (2-6), and one known compound (7) . The structures of cyclo(N-methyl-LPhe-L -Pro-L -Leu-D -Ile-L -Val) (1), and xylcarpins A-E (2-6) were elucidated by means of spectroscopic methods. The known compound (7) was identified as (4S,5S,6S)-5,6-epoxy-4-hydroxy-3-methoxy-5-methyl-cyclohex-2-en-1-one 15 by comparison with data in the literature. All of these compounds were tested for their cytotoxicities against five human cancer cell lines.
Results and Discussion
Compound 1 was obtained as a white powder. The molecular formula was established as C 32 (Figure 1 ), six fragments were established indicating that compound 1 comprised one leucine, one isoleucine, one valine, one proline and one phenylalanine. The HMBC correlation of δ H 3.47 (3H, s, Me-N) with δ C 58.2 (CH, α-carbon of the phenylalanine) suggested the methyl substitution at N-atom of phenylalane. In addition, the HMBC correlations also established the amino acids sequence to be N-methyl-Phe-Pro-Leu-Ile-Val (Figure 1 ). These data indicated that compound 1 was structurally the 
Compound 2 was purified as a white powder. The molecular formula was determined as C 15 (Table 2) showed signals for an oxymethine proton at δ H 3.41, three singlet methyl signals (δ H 0.76, 1.09, 1.15) and one doublet methyl signal (δ H 1.16, J = 8.0 Hz). The 13 C NMR and DEPT spectra (Table 2) showed 15 carbon resonances ascribable for four methyls, four methylenes, three methines (including one oxygen-bearing methine), and four quaternary carbons (one of which is a carbonyl carbon). Apart from one degree of unsaturation occupied by one carbonyl group, the remaining three degrees of unsaturation indicated that compound 2 should possess a three-ring system including one three-membered carbon ring according to the typical methylene signal at δ C 6.2. In the 1 H-1 H COSY spectrum, two fragments was established as shown with bold line in Figure 2 . These data suggested that compound 2 possessed a backbone related to the known compound thujopsene. 17 The major differences including a hydroxy group at C-3 (δ C 78.4) and a carbonyl group at C-2 (δ C 214.5) were established by the HMBC and (Table 2) were similar to those of 2 with the major differences being that the signal of the carbonyl carbon at C-2 was absent, showing instead a pair of double bond functionality between C-1 (δ C 135.5) and C-2 (δ C 114.6), which was supported by the HMBC correlations from δ H 1.80 (3H, s, H-11) to δ C 135.5 (s, C-1) and from δ H 1.76 (1H, m, H-3) to δ C 114.6 (d, C-2). The same ROESY correlations of 3 and 2 indicated their identical relative configuration. Therefore, compound 3 was established and named as xylcarpin B.
Compound 4 was obtained as a white powder. The IR spectrum showed the existence of hydroxy groups (3417 cm −1 ). The NMR data were quite similar to those of 3, except for the methyl at C-11 was oxygenated into a methylene (δ C 67.1), which was supported by the HMBC correlation of δ H 4.13 (2H, d, J = 4.8 Hz, H-11) with δ C 139.3 (s, C-1). Furthermore, the same ROESY data of 3 and 4 suggested the same relative configuration of them. Therefore, compound 4 was established as depicted, and named as xylcarpin C.
Compound 5 was isolated as a colorless oil with the molecular formula of C 15 were quite similar to those of (1R)-1-hydroxybisabololoxide B. 18 The hydroxy group was attached to C-4 as supported by the HMBC correlation from δ H 1.77 (3H, s, H-15) to δ C 68.8 (d, C-4). By comparison of the NMR spectroscopic data and the optical rotation data of (1R)-1-hydroxybisabololoxide B, 18 the relative configurations of C-6, C-7 and C-10 in 5 were deduced as same as those in (1R)-1-hydroxybisabololoxide B. In the ROESY spectrum, the correlation between H-4 and H-6 was not observed, indicating that the hydroxy group at C-4 should be α-oriented, which was also supported by the broad singlet of H-4. Compound 5 was established and named as xylcarpin D.
Compound 6 was obtained as colorless oil. The molecular formula of C 15 . 1D NMR data were very similar to those of compound 5 except for an oxygenated quaternary carbon at δ C 70.0 (s, C-6) in 6 instead of a methine in 5. Analysis of the HMBC spectrum suggested that one hydroxy group was placed at C-6 by the correlation of δ C 2.30 (1H, m, H-1) and 1.96 (1H, m, H-5) with δ C 70.0 (s, C-6). Detailed analysis of other 2D NMR data suggested that other parts of 6 were identical to those of 5. Therefore, compound 6 was established and named as xylcarpin E.
Compounds 17 were evaluated for their cytotoxicities against five hunman cancer cell lines using the MTT method as reported previously 19 . Compound 7 showed week cytotoxicity against four of the tested cell lines (Table 4) , while other compounds were inactive to all tested cell lines (IC 50 values of more than 40 μM).
Experimental Section
General Experimental Procedures. Optical rotations (OR) were recorded on a Jasco P-1020 digital polarimeter. Infrared spectroscopy (IR) spectra were obtained on a Bruker Tensor 27 FT-IR spectrometer with KBr pellets. Nuclear Magnetic Resonance (NMR) spectra were obtained on a Bruker Avance III 600 MHz spectrometer with tetramethylsilane (TMS) as an internal standard at room temperature. Electrospray ionizationmass spectra (ESI-MS) and high-resolution (HR) ESI-MS were recorded on a VG Autospec-3000 mass spectrometer and an API QSTAR Pulsar I spectrometer. Silica gel Extraction and Isolation. The culture broth (21 L) was filtered, and the filtrate was extracted three times with EtOAc while the mycelium was extracted three times with CH 3 ClMeOH (1:1). The EtOAc layer together with the mycelium extraction was concentrated under reduced pressure to give a crude extract (4.5 g), and this residue was subjected to CC over silica gel (200-300 mesh) eluted with a gradient of CH 3 Cl-MeOH (1:0 → 0:1) to obtain eight fractions (1) (2) (3) (4) (5) (6) (7) (8) . Fraction 2 (570 mg) applied to MPLC (MeOH-H 2 O, eluting from 50:50 to 100:0 for 100 mins with a flow of 20 mL/min) then isolated and purified by repeated silica gel chromatography, eluted with petroleum ether/EtOAc (2:1), followed by Sephadex LH-20 (Me 2 CO) to afford 2 (2.5 mg), 3 (0.7 mg), 5 (1.4 mg) and 7 (1.0 mg). Compound 1 (6 mg) precipitated from fraction 2. Fraction 3 (130 mg) was applied to MPLC (MeOH-H 2 O, eluting from 0:1 to 1:0 for 60 mins with a flow rate of 20 mL/min) to give four subfractions (3a-3d). Fraction 3d was subjected to silica gel, eluted with CH 3 Cl/Me 2 CO (10:1) to yield compound 4 (3 mg). Fraction 5 was isolated by preparative HPLC (MeCN-H 2 O, eluting from 0:100 to 50:50 for 50 mins followed by 50:50 to 100:0 for 30mins with a flow rate of 20 mL/min) to give a mixture, and compound 6 (2 mg) was separated from the mixtures by Sephadex LH-20 (Me 2 CO). Marfey's Reaction to Identify the Absolute Configuration of 1. Compound 1 (1.0 mg) was dissolved in 1 mL of 6 N HCl and heated at 120°C for 20 h. After that, the hydrolyzate must be evaporated to dryness under a stream of N 2 to remove traces of HCl. The hydrolyzate was added a 1% solution of L-FDDA (100 μL) in acetone and 1M NaHCO 3 (20 μL) , and the mixture was heated at 40℃ for 45 min. The standard amino acid L-Val and D-/L-Leu were treated the same way, and all the reactions must be stopped by addition of HCl (2 M; 10 μL). 16, 20 When all these sovents were evaporated, The N-[(dinitrophenyl)-5-L-alanine amide] amino acid derivatives were redissolved in MeCN-H 2 O (1:1) followed by HPLC analysis (Agilent 1100 liquid chromatography system equipped with a Zorbax SB-C18 column (4.6 mm × 150 mm); solvents: (A) water + 0.05% TFA, (B) MeCN; linear gradient: 0 min 10%, 40min 50%, 1 mL/min). HPLC analysis of the reaction products of the hydrolysate of compound 1 showed the presence of both L-Leu as well as L-Val.
Cytotoxicity Assay. Human myeloid leukemia HL-60, hepatocellular carcinoma SMMC-7721, lung cancer A-549 cells, breast cancer MCF-7 and colon cancer SW480 cell lines were used in the cytoxic assay. All the cells were cultured in RPMI-1640 or DMEM medium (Hyclone, USA), supplemented with 10% fetal bovine serum (Hyclone, USA) in 5% CO 2 at 37 C. The cytotoxicity assay was performed according to the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) method in 96-well microplates. 19 Briefly, 100 µL adherent cells were seeded into each well of 96-well cell culture plates and allowed to adhere for 12 h before drug addition, while suspended cells were seeded just before drug addition with initial density of 1 × 10 5 cells/mL. Each tumor cell line was exposed to the test compound dissolved in DMSO at concentrations of 0.0625, 0.32, 1.6, 8, and 40 μM in triplicates for 48 h, with cisplatin (Sigma, USA) as a positive control. After compound treatment, cell viability was detected and a cell growth curve was graphed. IC 50 values were calculated by Reed and Muench's method. 21 
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